Sees FY25 revenue $3.47B-$3.54B, consensus $3.57B. The company said, “Operational excellence and good progress with the integration of our strategic acquisitions have delivered significant organic operating margin improvements in the fourth quarter, fully offsetting the initial margin headwinds from our FY24 strategic M&A. We are confident in our ability to drive solid revenue growth, strong margin expansion and double-digit EPS growth in 2025, and beyond.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR:
- BRKR Earnings this Week: How Will it Perform?
- Trump Trade: President to impose 25% tariffs on steel, aluminum imports
- Bruker price target lowered to $65 from $69 at Barclays
- Bruker price target lowered to $76 from $80 at BofA
- U.S. places new export controls on biotech equipment, Reuters reports